Filing Details

Accession Number:
0000899243-21-016017
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-15 20:07:43
Reporting Period:
2021-04-14
Accepted Time:
2021-04-15 20:07:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689575 Katherine Stueland C/O Invitae Corporation
1400 16Th Street
San Francisco CA 94103
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-14 9,994 $39.38 199,770 No 4 S Direct
Common Stock Disposition 2021-04-14 9,799 $40.37 189,971 No 4 S Direct
Common Stock Disposition 2021-04-14 100 $41.02 189,871 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 15, 2020.
  2. Represents a weighted average sale price. Actual sale prices ranged from $38.98 to $39.97.
  3. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold.
  4. Includes an aggregate of 105,817 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  5. Represents a weighted average sale price. Actual sale prices ranged from $39.99 to $40.88.